Welcome to our dedicated page for Kellanova SEC filings (Ticker: K), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how rising cocoa prices hit Pringles® margins or when Kellanova’s executives sell shares before a new Pop-Tarts flavor can send you diving through hundreds of pages of disclosures. The company’s global mix of snack, cereal, and frozen brands means each 10-K and 10-Q is packed with segment data, currency notes, and risk factors that aren’t easy to spot.
Stock Titan’s AI reads every word the moment a document lands on EDGAR, then delivers plain-English answers to questions you actually ask—“Kellanova quarterly earnings report 10-Q filing results?” or “Kellanova insider trading Form 4 transactions”. Get Kellanova SEC filings explained simply with concise summaries, red-flag alerts, and side-by-side trend charts. Real-time notifications surface Kellanova Form 4 insider transactions, while our crawler parses each 8-K so Kellanova 8-K material events explained appears in minutes, not hours. Need compensation details? The proxy statement section outlines Kellanova executive compensation without legal jargon.
- Kellanova annual report 10-K simplified – segment revenue, commodity hedges, global tax exposure.
- Kellanova earnings report filing analysis – AI-highlighted quarter-over-quarter snack and cereal performance.
- Kellanova executive stock transactions Form 4 – live feed with dollar amounts and option grants.
Whether you monitor sustainability spending, currency impacts on Coco Pops®, or board-level pay in the Kellanova proxy statement executive compensation, our platform turns dense filings into actionable insight. Stop scrolling PDFs and start understanding Kellanova SEC documents with AI.
Kellanova (K) insider filing shows the W.K. Kellogg Foundation Trust sold 114,583 shares of K common stock on 08/14/2025 at a reported price of $80.0734 per share, leaving the Trust with 45,326,620 shares after the transaction. The filing identifies the Trust as a reporting person with the Foundation as sole beneficiary and lists trustees and Northern Trust Company acting as corporate trustee. The sale was made pursuant to trading instructions dated May 7, 2024 that are intended to comply with Rule 10b5-1(c).
Northern Trust Corporation reports beneficial ownership of 49,661,119 shares of Kellanova common stock, representing 14.3% of the class. The holding is reported as a mix of 3,331,001 shares with sole voting power and 46,327,324 shares with shared voting power; sole dispositive power is 3,267,978 and shared dispositive power is 46,358,785. The filing is a Schedule 13G, and includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
The Northern Trust Company is identified as the relevant subsidiary related to these holdings. The statement discloses material ownership levels and the allocation of voting and dispositive powers without indicating any intent to alter corporate control.
The W.K. Kellogg Foundation Trust reported a sale of 114,583 shares of Kellanova common stock on 08/07/2025 at an aggregate price of $79.97 per share. After the reported transaction, the Trust and related Foundation beneficially owned 45,441,203 shares.
The filing identifies the Trust as the reporting person with trustees named and the W.K. Kellogg Foundation as sole beneficiary. The sale was executed pursuant to trading instructions given on May 7, 2024 that are intended to comply with Rule 10b5-1(c), and the Form 4 discloses the transaction and resulting holdings.
Kellanova (K) Form 144 discloses that long-time shareholder W.K. Kellogg Foundation Trust plans to sell an additional 458,332 common shares through BofA Securities on or after 08-07-2025. At the recent market price used in the filing, the block is valued at $36.65 million.
The Trust has already sold 12 identical blocks of 114,583 shares between 05-07-2025 and 07-28-2025, totaling roughly 1.375 million shares and ≈$111 million in gross proceeds. Including the new notice, sales over the rolling three-month window would reach ≈1.83 million shares, or ≈0.53 % of Kellanova’s 345.2 million shares outstanding. The Trust acquired the stock via gifts and bequests dating back to 1970.
No officers or directors are named; therefore the filing reflects non-insider, charitable trust selling. While the percentage is modest, continued weekly liquidity events could create a short-term supply overhang and may be interpreted as incremental selling pressure.
Kellanova (K) – Form 4 insider transaction
On 07/28/2025 the W.K. Kellogg Foundation Trust, a designated 10 % owner, sold 114,583 common shares of Kellanova at an average price of $79.7883, raising about $9.1 million. After the sale the Trust still controls 45,555,786 shares, so the disposition reduced its position by roughly 0.25 %. The trade was executed under a Rule 10b5-1 plan adopted 05/07/2024, implying it was pre-programmed rather than opportunistic.
No derivative securities were reported and no other insiders filed concurrent transactions. Given the Trust’s large residual stake, the sale appears routine portfolio management and does not meaningfully alter Kellanova’s insider ownership profile.
FAQ
What is the current stock price of Kellanova (K)?
What is the market cap of Kellanova (K)?
